Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

This study has been completed.
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals ) Identifier:
First received: August 23, 2005
Last updated: May 9, 2013
Last verified: May 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2006
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)